Literature DB >> 11560567

Acute hyperhomocysteinaemia affects pulse pressure but not microvascular vasodilator function.

K R Davis1, H Pearson, S Moat, J R Bonham, R Donnelly.   

Abstract

AIMS: Raised homocysteine (hcy) levels are associated with premature coronary artery disease, but the underlying vascular mechanism and the extent to which hcy affects small vessel vasodilator responses (especially non-nitric oxide mediated pathways) are unclear.
METHODS: This double-blind, placebo-controlled crossover study in 14 healthy male subjects evaluated the effects of single-dose oral methionine 15 g (to induce acute hyperhomocysteinaemia) on cutaneous microvascular vasodilator responses to incremental-dose iontophoretic administration of acetylcholine (Ach) and sodium nitroprusside (SNP) using laser Doppler fluximetry (LDF), and the effects on von Willibrand factor (vWF) levels and systemic haemodynamics.
RESULTS: Methionine administration produced a three fold rise in plasma hcy levels at 8 h, which was accompanied by a significant increase in pulse pressure (53 vs 49 mmHg, P < 0.05) but no change in heart rate. Acute hyperhomocysteinaemia had no significant effect on incremental microvascular vasodilator dose-response curves to Ach and SNP, or circulating levels of vWF.
CONCLUSIONS: The present study shows that acute hyperhomocysteinaemia increases pulse pressure (a marker of large vessel stiffness) but has no effect on endothelial-dependent (non-NO-mediated) microvascular vasodilation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11560567      PMCID: PMC2014549          DOI: 10.1046/j.0306-5251.2001.01447.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  36 in total

1.  Plasma homocysteine levels and mortality in patients with coronary artery disease.

Authors:  O Nygård; J E Nordrehaug; H Refsum; P M Ueland; M Farstad; S E Vollset
Journal:  N Engl J Med       Date:  1997-07-24       Impact factor: 91.245

2.  High homocysteine levels are independently related to isolated systolic hypertension in older adults.

Authors:  K Sutton-Tyrrell; A Bostom; J Selhub; C Zeigler-Johnson
Journal:  Circulation       Date:  1997-09-16       Impact factor: 29.690

3.  Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

Authors:  I M Graham; L E Daly; H M Refsum; K Robinson; L E Brattström; P M Ueland; R J Palma-Reis; G H Boers; R G Sheahan; B Israelsson; C S Uiterwaal; R Meleady; D McMaster; P Verhoef; J Witteman; P Rubba; H Bellet; J C Wautrecht; H W de Valk; A C Sales Lúis; F M Parrot-Rouland; K S Tan; I Higgins; D Garcon; G Andria
Journal:  JAMA       Date:  1997-06-11       Impact factor: 56.272

4.  Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men.

Authors:  I J Perry; H Refsum; R W Morris; S B Ebrahim; P M Ueland; A G Shaper
Journal:  Lancet       Date:  1995-11-25       Impact factor: 79.321

5.  Homocysteine induced arteriosclerosis-like alterations of the aorta in normotensive and hypertensive rats following application of high doses of methionine.

Authors:  D Matthias; C H Becker; R Riezler; P H Kindling
Journal:  Atherosclerosis       Date:  1996-05       Impact factor: 5.162

6.  Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans.

Authors:  A Tawakol; T Omland; M Gerhard; J T Wu; M A Creager
Journal:  Circulation       Date:  1997-03-04       Impact factor: 29.690

7.  Skin blood flow responses to the iontophoresis of acetylcholine and sodium nitroprusside in man: possible mechanisms.

Authors:  S J Morris; A C Shore
Journal:  J Physiol       Date:  1996-10-15       Impact factor: 5.182

8.  Oxidation of low density lipoprotein by thiols: superoxide-dependent and -independent mechanisms.

Authors:  J W Heinecke; M Kawamura; L Suzuki; A Chait
Journal:  J Lipid Res       Date:  1993-12       Impact factor: 5.922

9.  Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis.

Authors:  J Selhub; P F Jacques; A G Bostom; R B D'Agostino; P W Wilson; A J Belanger; D H O'Leary; P A Wolf; E J Schaefer; I H Rosenberg
Journal:  N Engl J Med       Date:  1995-02-02       Impact factor: 91.245

10.  Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.

Authors:  M den Heijer; T Koster; H J Blom; G M Bos; E Briet; P H Reitsma; J P Vandenbroucke; F R Rosendaal
Journal:  N Engl J Med       Date:  1996-03-21       Impact factor: 91.245

View more
  3 in total

1.  D919G polymorphism of methionine synthase gene is associated with blood pressure response to benazepril in Chinese hypertensive patients.

Authors:  Yan Zhang; Minmin Zhang; Tianhua Niu; Xin Xu; Guoying Zhu; Yong Huo; Changzhong Chen; Xiaobin Wang; Houxun Xing; Shaojie Peng; Aiqun Huang; Xiumei Hong; Xiping Xu
Journal:  J Hum Genet       Date:  2004-05-18       Impact factor: 3.172

Review 2.  Homocysteine and blood pressure.

Authors:  Coen van Guldener; Prabath W B Nanayakkara; Coen D A Stehouwer
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

3.  Associations between plasma homocysteine levels, aortic stiffness and wave reflection in patients with arterial hypertension, isolated office hypertension and normotensive controls.

Authors:  G Vyssoulis; E Karpanou; S-M Kyvelou; D Adamopoulos; T Gialernios; E Gymnopoulou; D Cokkinos; C Stefanadis
Journal:  J Hum Hypertens       Date:  2009-06-11       Impact factor: 3.012

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.